Other
Matthew J O'Brien, PhD, BCBA-D
Total Trials
3
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
Failure Rate
0.0%
0 terminated/withdrawn out of 3 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed trials have results
Key Signals
1 recruiting
Enrollment Performance
Analytics
N/A
1(33.3%)
Early Phase 1
1(33.3%)
Phase 4
1(33.3%)
3Total
N/A(1)
Early Phase 1(1)
Phase 4(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (3)
Showing 3 of 3 trials
NCT07024303Early Phase 1Not Yet Recruiting
Measurement of Treatment Effects
Role: lead
NCT03420339Phase 4Recruiting
Stimulant Effects on Disruptive Behavior
Role: lead
NCT02456298Not ApplicableCompleted
Comparing Behavioral Assessments Using Telehealth for Children With Autism
Role: lead
All 3 trials loaded